Recommendations for Rotavirus Vaccine

Abstract

Rotavirus infection has been the leading cause of gastroenteritis among children in Taiwan. Studies have shown that 40% of hospitalization for acute gastroenteritis can be prevented through the use of vaccines, including a live, attenuated monovalent rotavirus vaccine and a pentavalent, human-bovine reassortant rotavirus vaccine. In 2009, the World Health Organization suggested that rotavirus vaccine should be included in all national immunization programs. This review summarizes issues and recommendations discussed during an expert meeting in Taiwan. The recommendations included: (1) rotavirus vaccine should be offered to all healthy infants (including those without contraindications, such as immunodeficiency) at an appropriate age; (2) either monovalent or pentavalent vaccine can be administered concurrently with routine injected vaccines; (3) the administration of rotavirus vaccine must be administered at least 2 weeks prior to oral polio vaccination; (4) the first vaccine dose for infants should be administered between age 6 weeks and age 14 weeks 6 days and the course should be completed by age 8 months 0 day; (5) pentavalent vaccines can be administered at 2 months, 4 months, and 6 months while monovalent vaccines can be taken at 2 months and 4 months; (6) a combined use of monovalent and pentavalent vaccine is justified only when the previous dose is unavailable or unknown; and (7) rotavirus vaccines may be given to premature infants, human immunodeficiency virus infected infants and infants who have received or are going to receive blood products.

Health care costs of influenza-related episodes in high income countries: A systematic review

“…The lowest cost per hospitalisation was reported in Korea (US$473) [ 32 ]; however, this cost is not fully comparable with other countries as the estimate includes only consultation, diagnostics and medication costs. In other countries, variations in hospitalization costs are still wide and range between US$ 1,419 in Hong Kong [ 40 ] and over US$ 7,000 in most US studies. In addition, in studies focusing on the overall ILI population, hospitalization rates varied in a range between near zero and 6%, that again may be attributed to within-study differences in the ILI population and other country-specific features.…”

Rotavirus vaccination and the risk of type 1 diabetes and celiac disease: A systematic review and meta-analysis

“…Rotavirus infection is the most common cause of acute gastroenteritis in children under 5 years of age worldwide (1). In 2009, the World Health Organization recommended that rotavirus vaccines be included in national immunization programs to prevent rotavirus gastroenteritis (2). Since its inclusion in routine immunization programs, gastroenteritis-and diarrhea-associated mortality has markedly decreased in young children, especially infants (3).…”

Effect of COVID-19 protective measures on the epidemiology characteristics of rotavirus, adenovirus, and coinfections among pediatric patients with acute gastroenteritis in Hangzhou, China

“…Vaccines have proven to be one of the most successful preventive measures in history, especially oral vaccines ( 35 ). Currently, two live attenuated rotavirus vaccines are available worldwide ( 36 ). However, the efficacy of these vaccines is relatively low, highlighting the need for the development of a highly effective rotavirus vaccine.…”